Publications by authors named "M Bessler"
Nonalcoholic fatty liver disease (NAFLD) is the most common global cause of chronic liver disease and remains under-recognized within healthcare systems. Therapeutic interventions are rapidly advancing for its inflammatory phenotype, nonalcoholic steatohepatitis (NASH) at all stages of disease. Diagnosis codes alone fail to recognize and stratify at-risk patients accurately.
View Article and Find Full Text PDFBackground: Patients with obesity who undergo bariatric surgery achieve sustained weight loss but are often left with excess skin folds that cause functional and psychological deficits. To remove excess skin, patients can undergo postbariatric BCS; however, cost and lack of insurance coverage present a significant barrier for many patients.
Objectives: This study aimed to characterize the financial impact of treatment on all patients who received bariatric surgery and to compare between those receiving only bariatric surgery and those with postbariatric BCS.
Article Synopsis
- The study investigated the impact of post-discharge apixaban, a blood thinner, on preventing venous thromboembolism (VTE) after bariatric surgery, which often sees higher thromboembolic events post-discharge.
- Apixaban was given to 60% of 2396 patients post-surgery, showing zero cases of VTE compared to five incidents (0.5%) in those not treated.
- Although patients taking apixaban experienced slightly more bleeding events, these were mostly self-resolving and did not significantly alter the need for urgent medical interventions.
Context: The prevalence of obesity is burgeoning among African American and Latina women; however, few studies investigating the skeletal effects of bariatric surgery have focused on these groups.
Objective: To investigate long-term skeletal changes following Roux-en-Y gastric bypass (RYGB) in African American and Latina women.
Design: Four-year prospective cohort study.